Deferred Tax Assets, Valuation Allowance of Minerva Neurosciences, Inc. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Minerva Neurosciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • Minerva Neurosciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $99,670,683, a 3.8% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Minerva Neurosciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $99,670,683 +$3,616,330 +3.8% 31 Dec 2025 10-K 11 Mar 2026 2025 FY
Q4 2024 $96,054,353 -$812,706 -0.84% 31 Dec 2024 10-K 11 Mar 2026 2025 FY
Q4 2023 $96,867,059 +$6,758,155 +7.5% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q4 2022 $90,108,904 +$8,758,416 +11% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q4 2021 $81,350,488 +$10,322,314 +15% 31 Dec 2021 10-K 08 Mar 2023 2022 FY
Q4 2020 $71,028,174 -$1,296,081 -1.8% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 $72,324,255 +$17,636,305 +32% 31 Dec 2019 10-K 08 Mar 2021 2020 FY
Q4 2018 $54,687,950 +$12,809,422 +31% 31 Dec 2018 10-K 09 Mar 2020 2019 FY
Q4 2017 $41,878,528 -$9,894,327 -19% 31 Dec 2017 10-K 12 Mar 2019 2018 FY
Q4 2016 $51,772,855 +$11,900,167 +30% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q4 2015 $39,872,688 +$10,322,875 +35% 31 Dec 2015 10-K 13 Mar 2017 2016 FY
Q4 2014 $29,549,813 +$20,728,283 +235% 31 Dec 2014 10-K 14 Mar 2016 2015 FY
Q4 2013 $8,821,530 31 Dec 2013 10-K 26 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.